DRUG · Unmapped registry intervention
CFI-402257
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors
NCT02792465
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Fulvestrant
Normalized identity: fulvestrantView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Solid Cancersunresolved
Breast Cancerverified · MONDO: breast cancer
Interventions
CFI-402257DRUG
FulvestrantDRUG · verified · RxNorm: fulvestrant
Sponsors & collaborators
University Health Network, Torontolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02792465 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.